EIF4A inhibition: Ready for primetime?

Tyler A. Cunningham; Eli Chapman; Jonathan H Schatz

doi:10.18632/oncotarget.26268

EIF4A inhibition: Ready for primetime?

Tyler A. Cunningham, Eli Chapman, Jonathan H Schatz

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	35515-35516
Number of pages	2
Journal	Oncotarget
Volume	9
Issue number	85
DOIs	https://doi.org/10.18632/oncotarget.26268
State	Published - Oct 1 2018

Keywords

Cap-dependent translation
Drug discovery
EIF4A
Experimental therapeutics
Signaling

ASJC Scopus subject areas

Oncology

Access to Document

10.18632/oncotarget.26268

Cite this

@article{a5aa7c945d85400eb6f96c2fedcd5d61,

title = "EIF4A inhibition: Ready for primetime?",

keywords = "Cap-dependent translation, Drug discovery, EIF4A, Experimental therapeutics, Signaling",

author = "Cunningham, {Tyler A.} and Eli Chapman and Schatz, {Jonathan H}",

year = "2018",

month = oct,

day = "1",

doi = "10.18632/oncotarget.26268",

language = "English (US)",

volume = "9",

pages = "35515--35516",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals",

number = "85",

}

TY - JOUR

T1 - EIF4A inhibition

T2 - Ready for primetime?

AU - Cunningham, Tyler A.

AU - Chapman, Eli

AU - Schatz, Jonathan H

PY - 2018/10/1

Y1 - 2018/10/1

KW - Cap-dependent translation

KW - Drug discovery

KW - EIF4A

KW - Experimental therapeutics

KW - Signaling

UR - http://www.scopus.com/inward/record.url?scp=85056097649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056097649&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.26268

DO - 10.18632/oncotarget.26268

M3 - Editorial

C2 - 30473746

AN - SCOPUS:85056097649

SN - 1949-2553

VL - 9

SP - 35515

EP - 35516

JO - Oncotarget

JF - Oncotarget

IS - 85

ER -

EIF4A inhibition: Ready for primetime?

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this